FAKTOR OPTIONSSCHEIN - BOSTON SCIENTIFIC | Market Closed - BOERSE MUENCHEN 10:26:53 2024-06-19 EDT | ||
| 32.43 EUR | +0.46% |
|
| Current month | +6.78% | ||
| 1 month | +8.00% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BOSTON SCIENTIFIC CORPORATION
| Date | Price | Change |
|---|---|---|
| 24-06-19 | 32.43 | +0.46% |
| 24-06-18 | 32.28 | -0.03% |
| 24-06-17 | 32.29 | -2.33% |
| 24-06-14 | 33.06 | +1.54% |
| 24-06-13 | 32.56 | -2.66% |
Real-time BOERSE MUENCHEN
Last update June 19, 2024 at 10:26 am
More quotesStatic data
| Product type | Exotische Produkte |
|---|---|
| Buy / Sell | CALL |
| Underlying | BOSTON SCIENTIFIC CORPORATION |
| Issuer | Goldman Sachs |
| WKN | GX52XB |
| ISIN | DE000GX52XB5 |
| Date issued | 2021-12-03 |
| Strike | 50.79 $ |
| Maturity | Unlimited |
| Parity | 0.74 : 1 |
| Emission price | 10.03 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 34.47 € |
|---|---|
| Lowest since issue | 6.05 € |
| Spread | 0.2 € |
| Spread % | 0.61% |
Company Profile
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:
- cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%);
- endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ;
- neuromodulation (2%).
The United States account for 59.2% of net sales.
Sector
-
Ratings for Boston Scientific Corporation
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Boston Scientific Corporation
Sell
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
76.31
USD
Average target price
82
USD
Spread / Average Target
+7.45%
- Stock Market
- Certificates
- Certificat
